Related Experiment Video
Updated: Feb 6, 2026

Isolation of Type I and Type II Pericytes from Mouse Skeletal Muscles
Published on: May 26, 2017
Primary mouse brain pericytes isolated from transgenic Alzheimer mice spontaneously differentiate into a CD11b+
Bianca Hutter-Schmid1, Christian Humpel1
1Laboratory of Psychiatry and Exp. Alzheimer's Research, Department of Psychiatry, Psychotherapy and Psychosomatics, Medical University of Innsbruck, Austria.
Abstract:
Alzheimer's disease (AD) is characterized by amyloid-β plaques, tau pathology and vascular impairment including pericyte damage. Pericytes are perivascular cells of the blood-brain barrier and can differentiate into different cell types in vitro including microglia. The aim of the present study is to explore if primary mouse brain pericytes isolated and cultured from transgenic AD (APP_SweDI) mice can differentiate into CD11b+ (integrin alpha M) microglia in vitro. We show that primary pericytes (passage 5) isolated from wildtype C57BL6 mice differentiated into CD11b+ microglia (Type B, >90%), when exposed to a differentiation factor mix of FGF-2, cAMP and fibronectin. This differentiation was time-dependent and seen as a large 80 kDa CD11b fragment (days 1-8) and a smaller 50 kDA CD11b fragment (>4 days). These pericytes did not differentiate into neurons, astroglia or oligodendroglia. However, pericytes isolated from transgenic AD mice differentiated into CD11b+ microglia (Type A, <10%) without addition of exogenous differentiation factors, displayed moderate Iba1+ immunostaining and phagocytic activity, but were still positive for PDGFRβ. In conclusion, we show for the first time that primary mouse pericytes from AD mice have the potential to spontanously differentiate in vitro into a CD11b+ microglial-like (Type A) cell type, but we do not provide evidence that these pericytic microglia display a full active microglial cell.
Insights
Alzheimer's disease pericytes can spontaneously transform into microglial-like cells in vitro. This study reveals a novel potential mechanism for cell differentiation in Alzheimer's disease research.
Area of Science:
- Neuroscience
- Cell Biology
- Pathology
Background:
- Alzheimer's disease (AD) involves amyloid plaques, tau pathology, and vascular issues, including pericyte damage.
- Pericytes, crucial for the blood-brain barrier, can differentiate into various cell types in vitro, including microglia.
Purpose of the Study:
- To investigate if primary mouse brain pericytes from AD model mice can differentiate into CD11b+ microglia in vitro.
- To explore spontaneous differentiation in AD pericytes versus induced differentiation in wildtype pericytes.
Main Methods:
- Isolation and culture of primary pericytes from wildtype and AD (APP_SweDI) transgenic mice.
- Induction of differentiation in wildtype pericytes using FGF-2, cAMP, and fibronectin.
- Analysis of cell differentiation markers (CD11b, Iba1, PDGFRβ) and phagocytic activity.
Main Results:
- Wildtype pericytes differentiated into CD11b+ microglia (Type B, >90%) upon exposure to differentiation factors.
- AD pericytes spontaneously differentiated into a small percentage of CD11b+ microglia (Type A, <10%) without added factors.
- AD-derived pericytic microglia showed moderate Iba1 staining and phagocytic activity but remained PDGFRβ positive.
Conclusions:
- Primary mouse pericytes from AD mice can spontaneously differentiate in vitro into a CD11b+ microglial-like cell type (Type A).
- This study provides the first evidence of spontaneous pericyte-to-microglia differentiation in an AD context.
- Further research is needed to determine if these pericytic microglia exhibit full microglial activity.
Related Concept Videos
Spontaneity
Transgenic Organisms
Alzheimer's Disease: Treatment
Primary and Secondary Growth in Roots and Shoots
iPS Cell Differentiation
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...

